Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-10

FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for Amphetamine Sulfate (amphetamine) by Amneal Pharmaceuticals NY LLC under ANDA211139, marking a regulatory action on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphetamine sulfate (amphetamine sulfate)

Snippet

SUPPL AP for AMPHETAMINE SULFATE (AMPHETAMINE)